# Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD

> **NCT03976700** · PHASE3 · UNKNOWN · sponsor: **Henan University of Traditional Chinese Medicine** · enrollment: 612 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Bufei Jianpi granule
- **DRUG:** Placebo Bufei Jianpi granule

## Key facts

- **NCT ID:** NCT03976700
- **Lead sponsor:** Henan University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 612 (ESTIMATED)
- **Last updated:** 2019-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03976700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03976700, "Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03976700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*